Correlation Between Stratasys and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Stratasys and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stratasys and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stratasys and Abcellera Biologics, you can compare the effects of market volatilities on Stratasys and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stratasys with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stratasys and Abcellera Biologics.
Diversification Opportunities for Stratasys and Abcellera Biologics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Stratasys and Abcellera is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Stratasys and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Stratasys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stratasys are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Stratasys i.e., Stratasys and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Stratasys and Abcellera Biologics
Given the investment horizon of 90 days Stratasys is expected to generate 1.22 times more return on investment than Abcellera Biologics. However, Stratasys is 1.22 times more volatile than Abcellera Biologics. It trades about 0.2 of its potential returns per unit of risk. Abcellera Biologics is currently generating about 0.02 per unit of risk. If you would invest 749.00 in Stratasys on August 30, 2024 and sell it today you would earn a total of 204.00 from holding Stratasys or generate 27.24% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.65% |
| Values | Daily Returns |
Stratasys vs. Abcellera Biologics
Performance |
| Timeline |
| Stratasys |
| Abcellera Biologics |
Stratasys and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stratasys and Abcellera Biologics
The main advantage of trading using opposite Stratasys and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stratasys position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Stratasys vs. Nano Dimension | Stratasys vs. IONQ Inc | Stratasys vs. D Wave Quantum | Stratasys vs. Desktop Metal |
| Abcellera Biologics vs. Ikena Oncology | Abcellera Biologics vs. Eliem Therapeutics | Abcellera Biologics vs. HCW Biologics | Abcellera Biologics vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |